Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 788 across all filing types
Latest filing 2023-06-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于不向下修正康医转债转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding the decision not to downward adjust the conversion price of its convertible bonds (康医转债). It details the bond issuance, listing, conversion period, and the conditions triggering price adjustments. The document includes resolutions from the board meeting and references regulatory approvals and disclosures. It is a formal announcement about a capital/financing matter related to convertible bonds, specifically about the conversion price adjustment decision. The document length is 2738 characters, which is relatively short but contains substantive information about financing terms and board decisions on convertible bonds. This fits the category of Capital/Financing Update (CAP) rather than a general regulatory filing or report publication announcement, as it provides detailed information on financing terms and board resolutions affecting capital structure.
2023-06-30 Chinese
关于可转换公司债券2023年付息的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the payment of interest on convertible bonds issued by 康泰医学系统（秦皇岛）股份有限公司. It details the interest payment date, interest rate, bond registration, tax treatment, and other related information. The document is relatively short (4129 characters) and focuses on the bond interest payment event rather than providing a full financial report or detailed financial statements. It does not contain comprehensive financial data or analysis typical of an Annual Report, Interim Report, or Earnings Release. It is not a regulatory certification or officer attestation. The content fits best with a Capital/Financing Update (CAP) as it relates to bond interest payment and financing activities. Therefore, the appropriate classification is CAP with high confidence.
2023-06-26 Chinese
康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券2023年跟踪评级报告
Audit Report / Information Classification · 95% confidence The document is a detailed credit rating report issued by a credit rating agency (联合资信评估股份有限公司) for 康泰医学系统（秦皇岛）股份有限公司 and its convertible bonds. It includes comprehensive financial data, credit rating results, risk analysis, industry and macroeconomic analysis, company background, bond issuance details, management changes, and legal proceedings updates. The document is lengthy (15,000 characters) and contains substantive financial and operational information rather than just an announcement or summary. It is not an annual report, earnings release, or management discussion but a standalone credit rating report focused on creditworthiness and bond rating. This fits the definition of an Audit Report / Information (AR), which includes standalone audit or credit rating reports and related financial assessments excluding full annual reports. Therefore, the appropriate classification is AR with high confidence. Q1 2023
2023-06-26 Chinese
关于预计触发可转债转股价格向下修正条件的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 康泰医学系统（秦皇岛）股份有限公司 regarding the expected triggering of a downward adjustment condition for the convertible bond conversion price. It details the bond issuance, conversion price, adjustment conditions, and the company's planned procedures if the adjustment is triggered. The document is regulatory in nature, providing information about bond terms and potential price adjustments, but it does not contain financial statements or detailed financial performance data. It is not an annual or interim report, earnings release, or audit report. It is also not a call transcript, management report, or investor presentation. The document is a formal disclosure related to capital instruments and their terms, specifically about convertible bond price adjustments, which fits best under Capital/Financing Update (CAP). The document length is 2688 characters, which is short but contains substantive information about financing terms and adjustments, not merely a report publication announcement or a brief notice. Therefore, the classification is CAP with high confidence.
2023-06-21 Chinese
关于康医转债恢复转股的提示性公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the resumption of convertible bond conversion rights after a suspension period related to the company's 2022 annual equity distribution. It includes bond codes, dates for suspension and resumption of conversion, and references a previous announcement. The document is only 746 characters long and primarily informs bondholders about the resumption date. It does not contain financial statements, detailed financial data, or comprehensive report content. It is an update on a capital market instrument activity rather than a full report or detailed financial disclosure. Therefore, it fits best under Capital/Financing Update (CAP).
2023-06-19 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司可转换公司债券转股价格调整的临时受托管理事务报告
Audit Report / Information Classification · 95% confidence The document is titled as a "临时受托管理事务报告" (Temporary Trustee Management Affairs Report) by 中信建投证券股份有限公司 regarding the adjustment of the convertible bond conversion price for 康泰医学系统（秦皇岛）股份有限公司. It details the adjustment of the convertible bond conversion price due to the 2022 annual dividend distribution, referencing relevant regulations and agreements. The document is a report prepared by the bond trustee to inform bondholders about the price adjustment and related matters. It is not a full annual report, audit report, earnings release, or other financial statement. It is a specific trustee management report related to bond issuance and management, which fits the category of Audit Report / Information (AR) as it relates to bond management and regulatory compliance but is not a full annual report or earnings release. The document length is 2449 characters, which is short but contains substantive information about bond price adjustment, not merely an announcement or certification. Therefore, the best classification is AR (Audit Report / Information). FY 2022
2023-06-19 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.